Variant of vitamin D receptor gene linked to melanoma risk

	Tweet

A new analysis indicates an association between a gene involved in vitamin D metabolism and skin cancer. Published in the November 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study suggests that individuals with certain variants in a vitamin D-related gene, called BsmI, may be at an increased risk of developing melanoma.

Research has shown that vitamin D in the body has significant protective effects against the development of cancer because it regulates cell growth, cell differentiation and cell death. This is supported by evidence that sun exposure, which helps in the production of vitamin D, can have anticancer effects.

Vitamin D exerts its effects by binding to a receptor located within cells. Because there are genetic differences in this vitamin D receptor among individuals, investigators suspect that different people have different levels of vitamin D activity within their bodies. Therefore, some individuals may naturally be able to achieve more vitamin D-related protection against cancer than others. However, study results on this topic have been conflicting, and no review of the available data has been performed to date.

To address this issue, Dr. Simone Mocellin and Dr. Donato Nitti of the University of Padova in Italy examined the existing research investigating the association between common variants in the vitamin D receptor and the risk of melanoma. The analysis revealed a significant association between melanoma risk and the BsmI gene.

The researchers note that additional research is needed to validate this link, and called for well-designed, population-based, large, multi-institutional studies to test whether any vitamin D receptor variant is independently associated with melanoma risk.

“These findings prompt further investigation on this subject and indirectly support the hypothesis that sun exposure might have an anti-melanoma effect through activation of the vitamin D system,” the authors wrote.

###

Article: “Vitamin D Receptor Polymorphisms and the Risk of Cutaneous Melanoma: A Systematic Review and Meta-Analysis.” Simone Mocellin and Donato Nitti. CANCER; Published Online: September 22, 2008 (DOI: 10.1002/cncr.23867); Print Issue Date: November 1, 2008.

Contact: David Sampson

American Cancer Society

RELATED STORIES:
Outdoor athletes have heightened skin cancer risk   Genetics of melanoma chemoresistance   Mayo Clinic study finds dramatic rise in skin cancer in young adults   Melanoma Is on the Rise in Women   New Option for Patients with Metastatic Melanoma   Tanning beds raise melanoma risk, US study finds   Potential Target for Skin Cancer Treatment   Researchers use zebrafish to identify new gene linked to melanoma   Childhood cancer survivors at risk of skin cancer   Light, chemistry, action—a new technique to target skin cancers?   Green Tea Helps   Risk of second malignant melanoma high   Scientists find gene mutation that drives melanoma   Documenting Skin Can Be Simple Way To Increase Accuracy of Self-Exam   Melanoma rates in kids continue to rise   Family History of Melanoma Linked to Parkinson’s Disease   Parents favor genetic testing for melanoma in their children   Panel backs skin cancer advice for youths   Study reveals possible link between IBD therapy and skin cancer   Stop signal discovered for skin cancer   Not Only Skin Deep: Penn Study on Skin Formation Suggests Strategies to Fight Skin Cancer   Lasers ID deadly skin cancer better than doctors

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]